Discover phases of acute ischemic stroke care, from rapid recognition to long-term recovery strategies that neurologists use ...

Q1 2025 net product revenue of $137.8 million, representing 75% year-over-year growth -- ARCALYST 2025 expected net product revenue increased to $590 - $605 million -- KPL-387 ...

DBV Technologies Reports First Quarter 2025 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT - CUSIP: 23306J309) ...

Bristol-Myers Squibb is undervalued with a 5%+ dividend yield, robust pipeline, and recession-resistant business. Click here ...

By connecting third-party systems and offering a complete picture of assets, vulnerabilities, and overall preparedness, Bearing empowers organizations to visualize their security posture, identify ...

Q1 2025 Earnings Conference Call April 30, 2025 7:00 AM ETCompany ParticipantsConstantin Fest - Head of IREmma Walmsley - CEOLuke Miels ...

With the first month of Q2 nearly over, May presents a fresh opportunity to enter the stock market despite ongoing volatility ...

Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Automated liquid handlers. Centrifuges. Flow cytometers ... IND ...

Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...

In a dynamic environment, an expert shares insights into potential AI applications in the clinical research setting at OCT ...

In a Phase 1b/2a trial for lymphoma and cytokine release syndrome, the first group's dose-limiting toxicity observation ...